ICD-11 · 6C42.2

Synthetic cannabinoid dependence

Synthetic cannabinoid dependence is a disorder of regulation of synthetic cannabinoid use arising from repeated or continuous use of synthetic cannabinoids. The characteristic feature is a strong internal drive to use synthetic cannabinoids, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use synthetic cannabinoids. Physiological features of dependence may also be present, including tolerance to the effects of synthetic cannabinoids, withdrawal symptoms following cessation or reduction in use of synthetic cannabinoids, or repeated use of synthetic cannabinoids or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if synthetic cannabinoid use is continuous (daily or almost daily) for at least 3 months.

ICD-11 diagnostic criteria

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid dependence are:

Differential diagnosis

When diagnosing Synthetic cannabinoid dependence, the following ICD-11 disorders should be considered in the differential diagnosis:

Frequently asked questions

How is Synthetic cannabinoid dependence diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Synthetic cannabinoid dependence (6C42.2) include: silne pragnienie używania syntetycznych kannabinoidów; utrata kontroli nad używaniem; kontynuowanie używania mimo szkód; tolerancja; objawy odstawienne.

What disorders are in the differential diagnosis of Synthetic cannabinoid dependence?

The differential diagnosis of Synthetic cannabinoid dependence (6C42.2) includes: Epizod szkodliwego używania syntetycznych kannabinoidów (6C42.0), Szkodliwy wzorzec używania syntetycznych kannabinoidów (6C42.1), Szkodliwy wzorzec używania syntetycznych kannabinoidów, epizodyczny (6C42.10), Szkodliwy wzorzec używania syntetycznych kannabinoidów, ciągły (6C42.11), Inne określone szkodliwe wzorce używania syntetycznych kannabinoidów (6C42.1Y), Szkodliwy wzorzec używania syntetycznych kannabinoidów, nieokreślony (6C42.1Z).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.2 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.